Skip to main content
Article
An investigation of critical factors in medical device development through Bayesian networks
Expert Systems with Applications (2013)
  • Lourdes A. Medina, University of Puerto Rico, Mayaguez
  • Marija Jankovic, Ecole Centrale Paris
  • Gül E. Kremer, The Pennsylvania State University
  • Bernard Yannou, Ecole Centrale Paris
Abstract
In this paper, we investigate the impact of product, company context and regulatory environment factors for their potential impact on medical device development (MDD). The presented work investigates the impact of these factors on the Food and Drug Administration’s (FDA) decision time for submissions that request clearance, or approval to launch a medical device in the market. Our overall goal is to identify critical factors using historical data and rigorous techniques so that an expert system can be built to guide product developers to improve the efficiency of the MDD process, and thereby reduce associated costs. We employ a Bayesian network (BN) approach, a well-known machine learning method, to examine what the critical factors in the MDD context are. This analysis is performed using the data from 2400 FDA approved orthopedic devices that represent products from 474 different companies. Presented inferences are to be used as the backbone of an expert system specific to MDD.
Publication Date
2013
DOI
10.1016/j.eswa.2013.06.014
Publisher Statement
In this paper, we investigate the impact of product, company context and regulatory environment factors for their potential impact on medical device development (MDD). The presented work investigates the impact of these factors on the Food and Drug Administration’s (FDA) decision time for submissions that request clearance, or approval to launch a medical device in the market. Our overall goal is to identify critical factors using historical data and rigorous techniques so that an expert system can be built to guide product developers to improve the efficiency of the MDD process, and thereby reduce associated costs. We employ a Bayesian network (BN) approach, a well-known machine learning method, to examine what the critical factors in the MDD context are. This analysis is performed using the data from 2400 FDA approved orthopedic devices that represent products from 474 different companies. Presented inferences are to be used as the backbone of an expert system specific to MDD.
Citation Information
Lourdes A. Medina, Marija Jankovic, Gül E. Kremer and Bernard Yannou. "An investigation of critical factors in medical device development through Bayesian networks" Expert Systems with Applications Vol. 40 Iss. 17 (2013) p. 7034 - 7045
Available at: http://works.bepress.com/gul-kremer/8/